Wegovy Injections: Weekly Dose Schedule Explained

Wegovy injections have become an increasingly discussed treatment option for people managing obesity and overweight-related health concerns. Because the medication is given once a week and the dose is gradually increased, many people want to understand exactly how the Wegovy injection schedule works, why the dose changes over time, and what to expect during each stage of treatment.

Wegovy contains semaglutide, a medication belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class. It is used alongside a reduced-calorie diet and increased physical activity for approved indications that include long-term weight management. In certain adults with established cardiovascular disease and overweight or obesity, Wegovy injection is also approved to reduce the risk of major cardiovascular events.

The weekly schedule is designed to help the body gradually adjust to semaglutide. Rather than beginning with the full maintenance dose, treatment generally starts at a low dose and increases every four weeks. This gradual approach is particularly important because gastrointestinal side effects can occur during treatment.

What Are Wegovy Injections and How Do They Work?
Wegovy injections contain semaglutide and are administered subcutaneously, meaning the medication is injected under the skin. Approved injection sites include the abdomen, thigh, or upper arm. The injection is normally given once a week, on the same day each week, and it can be taken at any time of day with or without food. Injection sites should be rotated.

Semaglutide works by activating GLP-1 receptors. These receptors are involved in appetite regulation, food intake, and other metabolic processes. For people using Wegovy for weight management, the treatment is intended to work together with healthy eating and increased physical activity rather than replace those habits.

One of the most important points about Wegovy injections is that the starting dose is not the final dose. The medication is gradually increased to give the body time to adjust.

The exact dose and duration of each stage should always be determined by the prescribing healthcare professional. A person should not increase the dose independently, even if weight loss seems slower than expected.

Wegovy Injections Weekly Dose Schedule
The standard Wegovy injection schedule begins with 0.25 mg once weekly and increases at four-week intervals. The current U.S. prescribing information lists the following escalation schedule for approved injection indications in adults and adolescents aged 12 and older:

Treatment period Once-weekly Wegovy injection dose
Weeks 1–4 0.25 mg
Weeks 5–8 0.5 mg
Weeks 9–12 1 mg
Weeks 13–16 1.7 mg
Week 17 onward Maintenance dose based on the approved indication
The gradual escalation is intended to reduce the likelihood and severity of gastrointestinal reactions. If a person does not tolerate a dose during escalation, the prescribing information states that dose escalation may be delayed for four weeks.

For adults using Wegovy for weight reduction, the maintenance dose may be 1.7 mg or 2.4 mg once weekly, with 2.4 mg generally recommended. Under the current labeling, certain adults who tolerate 2.4 mg for at least four weeks and require additional weight reduction may be considered for a higher 7.2 mg weekly dose, based on clinical circumstances and the approved indication.

This means that the schedule should not be viewed as a race toward the highest dose. Tolerability and treatment response are important considerations when determining an individual’s maintenance dose.

Why Does Wegovy Start at a Low Dose?
Starting Wegovy injections at a low dose allows the body to gradually become accustomed to semaglutide. The digestive system is particularly relevant because nausea, diarrhea, vomiting, constipation, abdominal discomfort, and other gastrointestinal symptoms are among the commonly reported adverse reactions.

Beginning with 0.25 mg does not mean that the medication is expected to produce its full treatment effect immediately. Instead, the initial stage is primarily part of the dose-escalation process.

As treatment progresses, the dose is increased gradually. Some people may experience relatively mild symptoms during escalation, while others may find certain dose increases more difficult to tolerate. This is one reason healthcare professionals may adjust the timing of dose increases rather than automatically moving forward according to the calendar.

Patients should report persistent or troublesome symptoms rather than stopping or changing the medication without professional guidance.

Adequate fluid intake can also be important, particularly if vomiting or diarrhea occurs. Severe gastrointestinal symptoms can contribute to dehydration, and the prescribing information includes warnings about kidney injury associated with volume depletion.

What to Expect During Each Stage of the Wegovy Schedule
During the first four weeks, the 0.25 mg weekly dose gives the body an opportunity to begin adjusting to semaglutide. Some people may notice changes in appetite or digestive symptoms during this period, while others may notice relatively little change.

Weeks five through eight typically involve an increase to 0.5 mg once weekly. For some people, this is when appetite-related effects become more noticeable. Gastrointestinal symptoms can also appear or temporarily become more noticeable following an increase.

During weeks nine through twelve, the standard dose increases to 1 mg weekly. By this stage, the body has already been exposed to the medication for several weeks, but individual responses can still vary considerably.

Weeks thirteen through sixteen generally involve 1.7 mg once weekly. This is another important adjustment period before reaching the maintenance stage.

From week seventeen onward, the appropriate maintenance dose depends on the individual’s treatment indication, response, and tolerability. For adult weight reduction, the current labeling allows 1.7 mg or 2.4 mg once weekly, with 2.4 mg listed as the recommended dose.

It is important to remember that the schedule provides a framework rather than a guarantee that every person will progress at exactly the same pace.

How Should a Weekly Wegovy Injection Be Taken?
Wegovy injections are designed to be taken once weekly. Keeping the injection on the same day each week can make the treatment easier to remember and can help establish a consistent routine.

The injection can be administered at any time of day and does not have to be coordinated with meals. It is given subcutaneously in an approved area such as the abdomen, thigh, or upper arm. The injection site should be rotated from one dose to another.

Before using an injection, the prescribed presentation and instructions should be understood clearly. Different Wegovy injection presentations can have different administration instructions, so patients should follow the instructions supplied with their particular device.

Patients who have been trained and are considered able to administer the medication properly may be able to self-inject. Proper training remains important, especially when a different injection device or presentation is prescribed.

Wegovy should not be shared between people. The current prescribing information specifically states that the Wegovy FlexTouch pen should never be shared between patients, even if the needle is changed.

What Happens If a Wegovy Dose Is Missed?
Missing a weekly dose does not necessarily mean that treatment has to be restarted from the beginning. However, the timing of the next scheduled dose matters.

According to the current prescribing information, if one Wegovy injection is missed and the next scheduled dose is more than two days away, the missed injection should be administered as soon as possible. If the next scheduled dose is less than two days away, the missed dose should be skipped and the regular weekly schedule resumed.

If two or more consecutive injection doses are missed, the prescribing information recommends that dose escalation may need to be restarted at a lower dose to reduce the risk of gastrointestinal reactions.

Because restarting or adjusting treatment can depend on the circumstances, anyone who has missed several doses should check with the prescribing healthcare professional before deciding how to continue.

Wegovy Side Effects and Important Safety Considerations
Wegovy injections are prescription medication and are not appropriate for everyone. Commonly reported adverse reactions include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, and other gastrointestinal symptoms.

More serious risks are also included in the prescribing information. These include acute pancreatitis, gallbladder disease, hypoglycemia when used with certain diabetes medications, kidney injury related to volume depletion, severe gastrointestinal reactions, and serious hypersensitivity reactions.

Wegovy also carries a boxed warning concerning thyroid C-cell tumors observed in rodents. It is unknown whether this risk applies to humans, but Wegovy is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Anyone experiencing severe or unusual symptoms should seek appropriate medical advice promptly. Symptoms such as severe abdominal pain, persistent vomiting, signs of a serious allergic reaction, or significant dehydration should not be ignored.

Wegovy can also delay gastric emptying and may affect the absorption of some oral medications. People taking other medicines should therefore make sure the prescribing healthcare professional knows about all current treatments.

Pregnancy is another important consideration. For weight-management or cardiovascular-risk-reduction treatment, the prescribing information states that Wegovy should be discontinued when pregnancy is recognized, and it recommends discontinuing treatment at least two months before a planned pregnancy because semaglutide has a long half-life.

Tips for Staying Consistent With the Weekly Wegovy Schedule
Consistency can make a weekly medication routine easier to manage. Some practical habits may help patients remember their Wegovy injections:

Choose a consistent weekly injection day.

Add the injection to a calendar or medication reminder.

Keep track of each dose and any symptoms that occur afterward.

Follow the prescribed escalation schedule rather than increasing the dose independently.

Stay attentive to hydration, particularly if gastrointestinal symptoms occur.

Follow the diet and physical-activity recommendations provided as part of the treatment plan.

Tell healthcare professionals about other medications and medical conditions.

Ask for guidance before changing the injection day, dose, or treatment schedule.

Most importantly, patients should understand that weight-management treatment is individualized. A person who loses weight quickly is not necessarily responding “better” than someone whose progress is more gradual. Treatment decisions generally take into account weight changes, health goals, side effects, other medical conditions, and how well the medication is tolerated.

Frequently Asked Questions About Wegovy Injections
1. How often are Wegovy injections taken?

Wegovy injections are administered once weekly. The injection can be taken at any time of day, with or without food, and it is generally given on the same day each week. Approved injection sites include the abdomen, thigh, and upper arm.

2. What is the starting dose of Wegovy injections?

The recommended starting dose is 0.25 mg once weekly for the first four weeks. The dose is then gradually increased every four weeks according to the prescribed schedule.

3. How quickly does the Wegovy dose increase?

The standard injection schedule increases the dose every four weeks: 0.25 mg for weeks 1–4, 0.5 mg for weeks 5–8, 1 mg for weeks 9–12, and 1.7 mg for weeks 13–16. The maintenance dose begins from week 17 and depends on the approved indication and individual treatment response.

4. Can the Wegovy dose be increased faster?

The dose should not be increased faster than prescribed. The gradual schedule is designed to reduce gastrointestinal adverse reactions. If a dose is not well tolerated, the prescribing information allows for consideration of delaying escalation rather than automatically moving to the next dose.

5. What happens if one Wegovy injection is missed?

If the next scheduled injection is more than two days away, the missed dose can generally be taken as soon as possible. If the next scheduled dose is less than two days away, the missed dose should generally be skipped and the regular schedule resumed. Different guidance applies when two or more consecutive doses have been missed.

6. Is 2.4 mg always the required maintenance dose?

Not necessarily. For adult weight reduction, the current prescribing information lists 1.7 mg or 2.4 mg once weekly as maintenance options, with 2.4 mg generally recommended. The appropriate dose depends on the approved indication, treatment response, and tolerability.

Wegovy injections are intended to be used as part of a broader treatment plan rather than as a standalone solution. Understanding the weekly dose schedule can help patients know what to expect, but the prescribed dose should always take priority over a general dosing chart. Any change to the dose, timing, or continuation of treatment should be discussed with a qualified healthcare professional.

Read More About Wegovy Injections: https://www.asianfanfics.com/blog/1355467/do-wegovy-injections-work-without-exercise